Tagged with R

UK There is much debate surrounding the potential impact on the UK’s life sciences industry of the country’s decision to leave the European Union. Here, IQVIA analysis posits ‘upside’ and ‘downside’ Brexit scenarios on pharmaceutical market sales and growth in the UK in comparison to a theoretical ‘No Brexit’ scenario. Different…

France Professor José-Alain Sahel, founder and director of the Institute de la Vision in Paris, offers his insider take on the ophthalmology landscape in France, international perceptions of the country, and the future of the Institute.   Could you please describe to our audience your career path and introduce the Institut…

Algeria Hepatitis C generics brought Beker to fame, but today its director general Rachid Kerrar discloses the new paths the company is exploring, such as new formulations and an increased focus on exports. He also praises the opportunities for business in pharmaceuticals in Algeria.   Rachid, Beker is most famous for…

Cyprus Healthcare and life science industry advisory services head at KPMG Cyprus, Iacovos Ghalanos, discusses the challenge of implementing the National Health Insurance Scheme, pricing pressures and how their innovative services help companies manage this crucial trend. Ghalanos also touches on the need for greater collaboration between the public and private…

Algeria Marko Ackermann of the German-Algerian Chamber of Commerce and Industry (AHK) discusses bringing German and Algerian companies together in partnerships, the investment landscape in Algeria, and the opportunities present in the country’s healthcare and life sciences sectors.   How would you describe the capabilities and offering of AHK in Algeria?…

Turkey Hakan Yurdakul, Head of Economy Monitoring and Coordination at the Presidency Office of the Republic of Turkey, elaborates on the strategic importance of the pharmaceutical and healthcare industries for the Turkish economy, while providing insights into the government’s vision for the sector as well as Turkey’s collaborative, outward-looking, and holistic…

Algeria Mohamed Benali Khoudja, GM for the Francophone Africa cluster at Abbott reveals the rationale behind creating a country cluster, discusses the market for local CMOs in Algeria, and expands on Abbott’s response to the recent import restrictions.   How easy has it been for you to transition from running GSK…

Turkey Prof. Dr. Temel Yilmaz, president of the Turkish Diabetes Foundation, discussed how the disease has made a massive impact in country and what can be done to tackle the issue before it develops further. He also shares how the organization is working to improve the lives of diabetes patients in…

Algeria Reform is under way in Algeria, and professor Mohamed L’Hadj presents the main themes of hospital reform encompassing the roll out of homecare, international collaboration and better training for better outcomes.   What main objectives and priorities are you pursuing today? Our objectives are geared towards our ambition to provide…

Malaysia Roberto Benetello, CEO of the EU-Malaysia Chamber of Commerce and Industry (EUMCCI), discusses the chamber’s function in Malaysia, the current business environment of the country, and the upcoming changes that will be faced by both local and foreign healthcare industry players.   What is the role of the EUMCCI? The…

Diversity Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson.   There is a clear correlation between an inclusive culture and innovation Creating a diverse workforce and an inclusive culture is key to an organisation’s success in today’s and tomorrow’s world. Organisations large and…

Algeria Ismael Chikhoune of the US-Algeria Business Council (US-ABC) expounds upon the evolving levels of business cooperation between the USA and Algeria, opportunities for US healthcare companies in Algeria, and the structural changes needed to cement Algeria as a top investment destination.   Could you inform our readers on your background…